Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Brainstorm Cell Therapeutics, Inc. (NASDAQ: BCLI) closed the day trading at $0.22 down -12.57% from the previous closing price of $0.25. In other words, the price has decreased by -$12.57 from its previous closing price. On the day, 0.54 million shares were traded. BCLI stock price reached its highest trading level at $0.248 during the session, while it also had its lowest trading level at $0.2201.
Ratios:
For a better understanding of BCLI, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.50 and its Current Ratio is at 0.50.
Maxim Group reiterated its Buy rating for the stock on December 19, 2016, while the target price for the stock was revised from $5 to $6.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 19 ’24 when Dagher Ibrahim B. sold 63,000 shares for $0.35 per share. The transaction valued at 22,069 led to the insider holds 0 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCLI now has a Market Capitalization of 17740836 and an Enterprise Value of 15233835.
Stock Price History:
Over the past 52 weeks, BCLI has reached a high of $0.79, while it has fallen to a 52-week low of $0.13. The 50-Day Moving Average of the stock is -26.71%, while the 200-Day Moving Average is calculated to be -41.90%.
Shares Statistics:
Over the past 3-months, BCLI traded about 432.36K shares per day on average, while over the past 10 days, BCLI traded about 357490 shares per day. A total of 79.73M shares are outstanding, with a floating share count of 72.45M. Insiders hold about 9.14% of the company’s shares, while institutions hold 15.34% stake in the company. Shares short for BCLI as of 1726185600 were 1399016 with a Short Ratio of 3.24, compared to 1723680000 on 1617894. Therefore, it implies a Short% of Shares Outstanding of 1399016 and a Short% of Float of 1.8599999999999999.
